Latest updates

ICGEB CRP Grants remain one of the Organisation’s most popular programmes and enjoy worldwide recognition.

The Biotech Development Unit has designed an online training module on the production process from the cell to the purified Active Pharmaceutical Ingredient. Access this rich eLearning platform.

Wednesday, 16 December 2020: the Interreg INCardio project kicks off. Lead Partner, ICGEB Trieste, together with the EURAC Research, Institute of Biomedicine, Medical University of Innsbruck, and the Carinthia University of Applied Sciences have launched an interregional project to promote European cooperation in cardiovascular research.

The ICGEB Cancer Genomics Group is featured in the Swiss-South Africa Joint Research Programme (SSAJRP) publication, featuring two of the Groups collaborative projects, led by Dr Luiz Zerbini.

ICGEB HQ, Trieste: 18 and 19 November 2020, more than 110 delegates from across the globe review and discuss ICGEB’s Biotech research initiatives, its efforts in the battle against Covid19, developing partnerships and capacity building for sustainable development.

Syncona Ltd announces the foundation of a new Syncona company, Purespring Therapeutics (Purespring) with a £45.0 million holding, involving ICGEB Intellectual Property.

With the support of New England Biolabs, the ICGEB Cape Town Component received SARS-CoV-2 Rapid Colorimetric LAMP assay kits.